Decentralized funding and decentralized science are a powerful combination that is democratizing the funding and science aspects of the risky but sometimes rewarding investments in new medicines for unmet medical needs. While IP ownership is regulated in a classical manner, IP-NFTs (Non-fungible tokens) allow for limited licensing to buyers. Smart contracting through the blockchain adds to automation of transfer of ownership and licensing. Typically, IP-NFT token owners are also directly involved in the voting of projects. The latter has clear advantages over the traditional top-down decision-making in corporate structures.
May 6, 13:00-13:45, room Rio
| Name | Position | Institution |
|---|---|---|
| Peter Groenen | Head Translational Science / Consultant | Cerebrum DAO / Alpinuity Bio GmbH |
| Name | Position | Institution |
|---|---|---|
| Brian Magierski | Founding steward, serial entrepreneur | Cerebrum DAO |
| Sebastian Gensior | Founder | Slate Mountain Capital |
| Antonella Santuccione Chadha | Founder, Chief Medical Officer, Board Member, Advisor | Women's Brain Foundation |
| Santosh Dixit | Chief Domain Expert (Healthcare and LifeSciences) Innovation Labs | Persistent Systems |
| Douglas Haggstrom | Lead, Antimicrobial Resistance & Life Sciences | Innovation Office University Basel |
Alpinuity Bio GmbH is providing hands-on support to biopharmaceutical companies, startups, investors, policy makers fir strategic decisions and project progress in non-clinical and early clinical development with a focus on improved translational and biomarker activities. The vast expertise in various indication areas and the extensive of experience from small, mid-size and big biopharmaceutical companies provide the right ingredients to work with you to become successful, pick the right project, perform the essential experiments, find the right strategy and deliver a successful proof of concept.
Cerebrum DAO is building the world’s largest, engaged community focused on funding and fostering the development of breakthroughs in solutions and therapeutics for extending our brain health and preventing the onset of neurodegeneration. Brain health is fundamental to our health span and longevity. The human brain is the final frontier of our health care. With populations aging in many nations across the world and health interventions extending lifespan, we now face the challenge of our bodies outliving our brains.
